Enhancing Real World Evidence through Combined Registry and Claims Data
Conducting burden of illness studies and cost-effectiveness research is challenging without data that captures a patient’s complete journey from primary care to specialty clinics and inpatient care. Closed claims data does an excellent job capturing all physician visits, hospital visits and prescription fills as documentation of this activity is required for a service to be reimbursed. However, what claims data lacks is the insight into disease activity and other metrics that are important to the care of the patient, but are not a required part of a reimbursement claim. Registry data fills this gap by providing deep clinical data to complement the broad patient treatment information that is captured in claims. The combination of these two assets provides insights into differences in segments of the population, including those with mild versus moderate or severe disease.
In this webinar, learn how this partnership between CorEvitas and Inovalon combines deep clinical data with applicable and authorized claims data in order to answer key questions in these complex disorders.
Our panelists discuss the benefits of this across HEOR studies and medical research in the immunology space, including case studies in Rheumatoid Arthritis.